Washington [US], October 19 (ANI): Researchers analyzed the structures of the receptor-binding domain (RBD) of the SARS-CoV-2 omicron variant and its receptor, angiotensin-converting enzyme 2 (ACE2), to gain insight into the variant's potential animal reservoir.